Janssen O, Scheffler A, Kabelitz D
Institute of Immunology, University of Heidelberg, Fed. Rep. of Germany.
Arzneimittelforschung. 1993 Nov;43(11):1221-7.
The in vitro effects of therapeutically administered mistletoe extracts (ABNOBAviscum) and pure mistletoe lectins (mainly mistletoe lectin I) on a variety of human and murine tumor cell lines have been investigated. Mistletoe extracts and purified mistletoe lectins inhibited in vitro the growth of all tumor cell lines tested including B cell hybridomas, P815, EL-4, Ke37, MOLT-4 and U937. The mechanism of growth arrest was shown to be due to the induction of programmed cell death (apoptosis). Thus, fragmentation of genomic DNA into oligonucleosomal bands of approximately 200 base pairs in length was observed within 20 h when tumor cells were incubated with mistletoe extracts or lectins. These data point to a rational basis for the direct cytotoxic effects of mistletoe extracts and lectins apart from the postulated immunostimulatory properties of these agents.
已经研究了治疗性应用的槲寄生提取物(ABNOBAviscum)和纯槲寄生凝集素(主要是槲寄生凝集素I)对多种人类和小鼠肿瘤细胞系的体外作用。槲寄生提取物和纯化的槲寄生凝集素在体外抑制了所有测试的肿瘤细胞系的生长,包括B细胞杂交瘤、P815、EL-4、Ke37、MOLT-4和U937。生长停滞的机制被证明是由于程序性细胞死亡(凋亡)的诱导。因此,当肿瘤细胞与槲寄生提取物或凝集素一起孵育时,在20小时内观察到基因组DNA断裂成大约200个碱基对长度的寡核小体条带。这些数据为槲寄生提取物和凝集素的直接细胞毒性作用提供了合理依据,而不仅仅是这些药物假定的免疫刺激特性。